Self-induced secondary hyperaldosteronism simulating Bartter's syndrome.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 4647211)

Published in Isr J Med Sci on November 01, 1972

Authors

D Ben-Ishay, M Levy, D Birnbaum

Articles citing this

The clinical features of covert diuretic use. West J Med (1982) 1.38

Metabolic abnormality induced by streptomycin. BMJ (1994) 0.75

Articles by these authors

(truncated to the top 100)

Genome sequence of the plant pathogen Ralstonia solanacearum. Nature (2002) 6.23

Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene (2006) 4.85

The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78

Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature (1983) 4.44

Familial Mediterranean fever. Lancet (1998) 4.16

Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet (1994) 4.12

Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature (2000) 3.61

Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med (1974) 3.57

New human transforming genes detected by a tumorigenicity assay. Mol Cell Biol (1984) 3.43

General practice audit of asthma in childhood. Br Med J (Clin Res Ed) (1984) 2.98

ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nat Cell Biol (2000) 2.90

BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene (1991) 2.89

Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect Immun (1996) 2.80

Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia (2009) 2.77

Histoprognostic grade in BRCA1-associated breast cancer. Lancet (1995) 2.47

Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med (1994) 2.45

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril (2001) 2.44

Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. J Pathol (1998) 2.40

WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene (2001) 2.32

Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol (2001) 2.30

Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family. Oncogene (1989) 2.20

Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma? Ann Oncol (2005) 2.20

Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet (2000) 2.15

Amplification and purification of UvrA, UvrB, and UvrC proteins of Escherichia coli. J Biol Chem (1985) 2.11

Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer (1995) 2.05

Boy Scouts of America policy on homosexuality. Arch Pediatr Adolesc Med (2001) 2.03

Characterization of an activated human ros gene. Mol Cell Biol (1986) 1.97

Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet (1999) 1.96

Paracetamol overdose in Jerusalem, 1984-89. Isr J Med Sci (1992) 1.91

Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. Lancet (2001) 1.90

Mesenteric panniculitis: review of the leterature and presentation of cases. Surgery (1977) 1.83

FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation (1994) 1.80

Alport's syndrome. A report of 58 cases and a review of the literature. Am J Med (1981) 1.78

A refined molecular taxonomy of breast cancer. Oncogene (2011) 1.78

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia (2010) 1.75

Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1994) 1.69

Strategy for the detection of Helicobacter species by amplification of 16S rRNA genes and identification of H. felis in a human gastric biopsy. Res Microbiol (1997) 1.65

SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias. Leukemia (2013) 1.65

Collective nomenclature for LAP proteins. Nat Cell Biol (2000) 1.64

Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection (2009) 1.64

Lawsonia intracellularis proliferative enteropathy in a weanling foal. Equine Vet J (1998) 1.63

Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int (1975) 1.59

Impact of pretransplant renal function on survival after liver transplantation. Transplantation (1995) 1.58

Ancient large-scale genome duplications: phylogenetic and linkage analyses shed light on chordate genome evolution. Mol Biol Evol (1998) 1.57

H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int (1986) 1.55

Concentration by evaporation and the prebiotic synthesis of cytosine. Orig Life Evol Biosph (2001) 1.54

Risk factors for breast cancer. Am J Epidemiol (1983) 1.54

Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet (2001) 1.54

Characteristics of pregnant women who engage in binge alcohol consumption. CMAJ (1997) 1.53

Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf (2000) 1.51

Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology (1995) 1.51

Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families. J Mol Evol (1997) 1.51

Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most. Intern Med J (2007) 1.50

Surgical removal of echocardiographically detected multiple pedunculated and mobile left ventricular thrombi in acute myocardial infarction. Isr J Med Sci (1989) 1.49

Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma. Cytogenet Cell Genet (1997) 1.48

Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias. Leukemia (2009) 1.45

Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene (1991) 1.44

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene (2008) 1.44

Basal breast cancer: a complex and deadly molecular subtype. Curr Mol Med (2012) 1.43

Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med (2004) 1.42

Expression of the Fgf6 gene is restricted to developing skeletal muscle in the mouse embryo. Development (1993) 1.41

Unscientific assertions on treating asthma in general practice. BMJ (1994) 1.41

Limitations of the captopril test in the diagnosis of renovascular hypertension. Isr J Med Sci (1991) 1.40

Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum Mol Genet (1999) 1.39

Blood pressure measurement method not responsible for results of Brands et al. Am J Hypertens (1994) 1.39

Familial Mediterranean fever in the "Chuetas" of Mallorca--origin in inquisition? Isr J Med Sci (1995) 1.39

Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res (1998) 1.39

Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene (1999) 1.39

Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia (1996) 1.38

Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther (1978) 1.38

Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease. J Pathol (1996) 1.38

Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood (1992) 1.37

Colchicine: 1998 update. Semin Arthritis Rheum (1998) 1.36

Evaluation of a yoga based regimen for treatment of osteoarthritis of the hands. J Rheumatol (1994) 1.35

The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol (1978) 1.35

Prison health services. BMJ (1997) 1.35

Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res (1997) 1.33

Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol (2004) 1.33

Bilateral spontaneous and simultaneous rupture of the quadriceps tendons in gout. J Bone Joint Surg Br (1971) 1.33

Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood (1993) 1.32

Polymorphic acetylation procainamide in man. Clin Pharmacol Ther (1975) 1.32

Alpha heavy chain disease. A variant of Mediterranean lymphoma. Arch Intern Med (1971) 1.32

The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene (1993) 1.32

The use of glucose oxidase as a generator of H 2 O 2 in the enzymatic radioiodination of components of cell surfaces. Cell Immunol (1972) 1.31

Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood (1997) 1.30

MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer (2000) 1.30

Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res (2000) 1.29

Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer (1994) 1.27

Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique. Leukemia (2008) 1.27

Submicrometer intracellular chemical optical fiber sensors. Science (1992) 1.26

Alport's syndrome: experience at Hôpital Necker. Kidney Int Suppl (1982) 1.25

Educating the student, informing the physician on nutrition. J Med Assoc Ga (1980) 1.24

Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene (2006) 1.23

Effect of co-trimoxazole on normal creatinine clearance. Lancet (1978) 1.23

Breast cancer and alcoholic-beverage consumption. Lancet (1982) 1.22

Murine FGF-12 and FGF-13: expression in embryonic nervous system, connective tissue and heart. Mech Dev (1997) 1.22

Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol (1974) 1.21

Large scale physical mapping in the q27 region of the human X chromosome: the coagulation factor IX gene and the mcf.2 transforming sequence are separated by at most 270 kilobase pairs and are surrounded by several 'HTF islands'. EMBO J (1987) 1.21

Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res (1996) 1.21

The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood (1999) 1.21